Related Experiment Videos
Decreased production of interleukin-1 by monocytes from patients with lipoid nephrosis
1Second Department of Internal Medicine, Nibon University School of Medicine, Tokyo, Japan.
Abstract:
In order to further characterize monocyte function in patients with lipoid nephrosis (LN), we studied the production of interleukin-1 (IL-1). In this study we examined the ability of peripheral blood monocytes (PBM) from LN patients to produce this monokine in vitro under the stimulus of bacterial lipopolysaccharide (LPS). The levels of IL-1 were decreased in patients with LN compared with those in normal controls and lower in LN patients with nephrotic syndrome (NS) than in those without NS. In contrast, the values in IgA nephropathy (IgAN) patients with or without NS did not differ from normal subjects. The addition of indomethacin, an inhibitor of prostaglandin synthesis, partially restored this defect. These results suggest that the impaired IL-1 production of LN PBM is probably attributable, at least in part, to increased prostaglandin production and possibly influences the immune status of LN patients.
Insights
Monocyte function in lipoid nephrosis (LN) patients shows reduced interleukin-1 (IL-1) production, potentially due to increased prostaglandin synthesis. This finding may impact the immune status of individuals with LN.
Area of Science:
- Immunology
- Nephrology
Background:
- Lipoid nephrosis (LN) is a kidney disease affecting monocyte function.
- Interleukin-1 (IL-1) is a key monokine involved in immune responses.
Purpose of the Study:
- To investigate interleukin-1 (IL-1) production by peripheral blood monocytes (PBM) in patients with lipoid nephrosis (LN).
- To compare IL-1 production in LN patients with and without nephrotic syndrome (NS) against normal controls and IgA nephropathy (IgAN) patients.
Main Methods:
- Peripheral blood monocytes (PBM) were isolated from LN patients and healthy controls.
- PBM were stimulated in vitro with bacterial lipopolysaccharide (LPS) to assess IL-1 production.
- Indomethacin, a prostaglandin synthesis inhibitor, was added to evaluate its effect on IL-1 production.
Main Results:
- IL-1 levels were significantly decreased in LN patients compared to normal controls.
- LN patients with NS exhibited lower IL-1 levels than those without NS.
- IL-1 production in IgA nephropathy (IgAN) patients was comparable to normal subjects.
- Indomethacin partially restored IL-1 production in LN patients.
Conclusions:
- Impaired IL-1 production in LN PBM is likely linked to increased prostaglandin synthesis.
- Altered IL-1 production may contribute to the immune dysregulation observed in LN patients.